Global Endometriosis Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Endometriosis Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2048125
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and periods lasting over 7 days, among others. Moreover, the impending treatment of endometriosis market may lead to infertility, formation of ovarian cysts, inflammation, and scar tissue and adhesion development, among others.
The Endometriosis market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Endometriosis market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Endometriosis Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Endometriosis market are:
Bayer Ag
Takeda Pharmaceutical Company Limited
Orphagen Pharmaceuticals, inc.
Evestra, Inc.
Myovant Sciences ltd.
Neurocrine Biosciences, Inc.
Abbott
Obseva SA
Astellas Pharma Inc.
Abbvie Inc.
Forendo Pharma
Repros Therapeutics Inc.
Meditrina Pharmaceuticals
Sanofi
Elexopharm
Astrazeneca
Ipsen
Philogen
Teva Pharmaceutical Industries ltd.
Allergan
Addex Therapeutics
Valirx
Pfizer, Inc.
Debiopharm Group
Ogeda S.A.
Kissei Pharmaceutical Co., ltd.

Most important types of Endometriosis products covered in this report are:
Ultrasound
Pelvic exam
Laparoscopy
Magnetic Resonance Imaging (MRI)
Hysteroscopy
Sonohysterography

Most widely used downstream fields of Endometriosis market covered in this report are:
Hospitals
Clinics
Research Institutes

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Endometriosis Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Endometriosis
1.3 Endometriosis Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Endometriosis Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Endometriosis
1.4.2 Applications of Endometriosis
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Endometriosis Industry Trends
1.5.2 Endometriosis Drivers
1.5.3 Endometriosis Market Challenges
1.5.4 Endometriosis Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Endometriosis Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Endometriosis Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Endometriosis Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Endometriosis
2.2.1 Major Players Manufacturing Base of Endometriosis in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Endometriosis Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Endometriosis
2.3.3 Labor Cost of Endometriosis
2.4 Market Channel Analysis of Endometriosis
2.5 Major Down Stream Customers by Application

3 Global Endometriosis Market, by Type
3.1 Global Endometriosis Revenue and Market Share by Type (2018-2021)
3.2 Global Endometriosis Production and Market Share by Type (2018-2021)
3.3 Global Endometriosis Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Endometriosis Revenue and Growth Rate of Ultrasound
3.3.2 Global Endometriosis Revenue and Growth Rate of Pelvic exam
3.3.3 Global Endometriosis Revenue and Growth Rate of Laparoscopy
3.3.4 Global Endometriosis Revenue and Growth Rate of Magnetic Resonance Imaging (MRI)
3.3.5 Global Endometriosis Revenue and Growth Rate of Hysteroscopy
3.3.6 Global Endometriosis Revenue and Growth Rate of Sonohysterography
3.4 Global Endometriosis Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Endometriosis Market, by Application
4.1 Downstream Market Overview
4.2 Global Endometriosis Consumption and Market Share by Application (2018-2021)
4.3 Global Endometriosis Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Endometriosis Consumption and Growth Rate of Hospitals (2018-2021)
4.3.2 Global Endometriosis Consumption and Growth Rate of Clinics (2018-2021)
4.3.3 Global Endometriosis Consumption and Growth Rate of Research Institutes (2018-2021)

5 Global Endometriosis Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Endometriosis Revenue and Market Share by Region (2018-2021)
5.2 Global Endometriosis Consumption and Market Share by Region (2018-2021)
5.3 Global Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Endometriosis Market Under COVID-19
5.4.2 North America Endometriosis SWOT Analysis
5.5 Europe Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Endometriosis Market Under COVID-19
5.5.2 Europe Endometriosis SWOT Analysis
5.6 China Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Endometriosis Market Under COVID-19
5.6.2 China Endometriosis SWOT Analysis
5.7 Japan Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Endometriosis Market Under COVID-19
5.7.2 Japan Endometriosis SWOT Analysis
5.8 Middle East and Africa Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Endometriosis Market Under COVID-19
5.8.2 Middle East and Africa Endometriosis SWOT Analysis
5.9 India Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Endometriosis Market Under COVID-19
5.9.2 India Endometriosis SWOT Analysis
5.10 South America Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Endometriosis Market Under COVID-19
5.10.2 South America Endometriosis SWOT Analysis
5.11 South Korea Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Endometriosis Market Under COVID-19
5.11.2 South Korea Endometriosis SWOT Analysis
5.12 Southeast Asia Endometriosis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Endometriosis Market Under COVID-19
5.12.2 Southeast Asia Endometriosis SWOT Analysis

6 Global Endometriosis Production by Top Regions (2018-2021)
6.1 Global Endometriosis Production by Top Regions (2018-2021)
6.2 North America Endometriosis Production and Growth Rate
6.3 Europe Endometriosis Production and Growth Rate
6.4 China Endometriosis Production and Growth Rate
6.5 Japan Endometriosis Production and Growth Rate
6.6 India Endometriosis Production and Growth Rate

7 Global Endometriosis Consumption by Regions (2018-2021)
7.1 Global Endometriosis Consumption by Regions (2018-2021)
7.2 North America Endometriosis Consumption and Growth Rate
7.3 Europe Endometriosis Consumption and Growth Rate
7.4 China Endometriosis Consumption and Growth Rate
7.5 Japan Endometriosis Consumption and Growth Rate
7.6 Middle East & Africa Endometriosis Consumption and Growth Rate
7.7 India Endometriosis Consumption and Growth Rate
7.8 South America Endometriosis Consumption and Growth Rate
7.9 South Korea Endometriosis Consumption and Growth Rate
7.10 Southeast Asia Endometriosis Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Bayer Ag Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Endometriosis Product Profiles, Application and Specification
8.2.3 Bayer Ag Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Takeda Pharmaceutical Company Limited Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Endometriosis Product Profiles, Application and Specification
8.3.3 Takeda Pharmaceutical Company Limited Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Orphagen Pharmaceuticals, inc. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Endometriosis Product Profiles, Application and Specification
8.4.3 Orphagen Pharmaceuticals, inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Evestra, Inc. Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Endometriosis Product Profiles, Application and Specification
8.5.3 Evestra, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Myovant Sciences ltd. Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Endometriosis Product Profiles, Application and Specification
8.6.3 Myovant Sciences ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Neurocrine Biosciences, Inc. Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Endometriosis Product Profiles, Application and Specification
8.7.3 Neurocrine Biosciences, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Abbott Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Endometriosis Product Profiles, Application and Specification
8.8.3 Abbott Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Obseva SA Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Endometriosis Product Profiles, Application and Specification
8.9.3 Obseva SA Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Astellas Pharma Inc. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Endometriosis Product Profiles, Application and Specification
8.10.3 Astellas Pharma Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Abbvie Inc. Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Endometriosis Product Profiles, Application and Specification
8.11.3 Abbvie Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Forendo Pharma Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Endometriosis Product Profiles, Application and Specification
8.12.3 Forendo Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Repros Therapeutics Inc. Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Endometriosis Product Profiles, Application and Specification
8.13.3 Repros Therapeutics Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Meditrina Pharmaceuticals Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Endometriosis Product Profiles, Application and Specification
8.14.3 Meditrina Pharmaceuticals Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Sanofi Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Endometriosis Product Profiles, Application and Specification
8.15.3 Sanofi Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Elexopharm Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Endometriosis Product Profiles, Application and Specification
8.16.3 Elexopharm Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Astrazeneca Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Endometriosis Product Profiles, Application and Specification
8.17.3 Astrazeneca Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Ipsen Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Endometriosis Product Profiles, Application and Specification
8.18.3 Ipsen Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Philogen Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Endometriosis Product Profiles, Application and Specification
8.19.3 Philogen Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 Teva Pharmaceutical Industries ltd. Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Endometriosis Product Profiles, Application and Specification
8.20.3 Teva Pharmaceutical Industries ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Allergan Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Endometriosis Product Profiles, Application and Specification
8.21.3 Allergan Sales, Revenue, Price, Gross Margin 2018-2021
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 Addex Therapeutics Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Endometriosis Product Profiles, Application and Specification
8.22.3 Addex Therapeutics Sales, Revenue, Price, Gross Margin 2018-2021
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19
8.23 Valirx Market Performance Analysis
8.23.1 Company Profiles
8.23.2 Endometriosis Product Profiles, Application and Specification
8.23.3 Valirx Sales, Revenue, Price, Gross Margin 2018-2021
8.23.4 Company Recent Development
8.23.5 Strategies for Company to Deal with the Impact of COVID-19
8.24 Pfizer, Inc. Market Performance Analysis
8.24.1 Company Profiles
8.24.2 Endometriosis Product Profiles, Application and Specification
8.24.3 Pfizer, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.24.4 Company Recent Development
8.24.5 Strategies for Company to Deal with the Impact of COVID-19
8.25 Debiopharm Group Market Performance Analysis
8.25.1 Company Profiles
8.25.2 Endometriosis Product Profiles, Application and Specification
8.25.3 Debiopharm Group Sales, Revenue, Price, Gross Margin 2018-2021
8.25.4 Company Recent Development
8.25.5 Strategies for Company to Deal with the Impact of COVID-19
8.26 Ogeda S.A. Market Performance Analysis
8.26.1 Company Profiles
8.26.2 Endometriosis Product Profiles, Application and Specification
8.26.3 Ogeda S.A. Sales, Revenue, Price, Gross Margin 2018-2021
8.26.4 Company Recent Development
8.26.5 Strategies for Company to Deal with the Impact of COVID-19
8.27 Kissei Pharmaceutical Co., ltd. Market Performance Analysis
8.27.1 Company Profiles
8.27.2 Endometriosis Product Profiles, Application and Specification
8.27.3 Kissei Pharmaceutical Co., ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.27.4 Company Recent Development
8.27.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Endometriosis Market Analysis and Forecast by Type and Application
9.1 Global Endometriosis Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Ultrasound Market Revenue and Volume Forecast (2021-2026)
9.1.2 Pelvic exam Market Revenue and Volume Forecast (2021-2026)
9.1.3 Laparoscopy Market Revenue and Volume Forecast (2021-2026)
9.1.4 Magnetic Resonance Imaging (MRI) Market Revenue and Volume Forecast (2021-2026)
9.1.5 Hysteroscopy Market Revenue and Volume Forecast (2021-2026)
9.1.6 Sonohysterography Market Revenue and Volume Forecast (2021-2026)
9.2 Global Endometriosis Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospitals Market Revenue and Volume Forecast (2021-2026)
9.2.2 Clinics Market Revenue and Volume Forecast (2021-2026)
9.2.3 Research Institutes Market Revenue and Volume Forecast (2021-2026)

10 Endometriosis Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Endometriosis Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Biotechnology Industry